mRNAプラットフォーム市場：適応症別、有用性別、mRNAタイプ別、エンドユーザー別-2023-2030年の世界予測

mRNAプラットフォームの世界市場は、2023年にCAGR 49.67%で84億58万米ドルと予測され、2030年には驚異的な1,548億2,021万米ドルに達すると予測され、大きく成長すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のmRNAプラットフォーム市場を評価するために不可欠です。事業戦略や製品満足度などの主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.mRNAプラットフォームの世界市場規模および予測は？

2.予測期間中、世界のmRNAプラットフォーム市場を形成するCOVID-19の阻害要因と影響は？

3.mRNAプラットフォームの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.mRNAプラットフォームの世界市場における競争戦略は？

5.mRNAプラットフォームの世界市場における技術動向と規制の枠組みは？

6.mRNAプラットフォームの世界市場における主要ベンダーの市場シェアは？

7.mRNAプラットフォームの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 他のワクチン療法に比べてmRNAに大きな利点がある
    • mRNAプラットフォームを活用したがん治療法の開発
    • ワクチン開発と商品化のスケジュールを短縮する必要がある
  • 抑制要因
    • 製造および商業経路の最適化における複雑さ
  • 機会
    • 時価総額の増加と公的資金の投入
    • オンデマンドワクチン開発におけるmRNA技術の最適化
    • 予防ワクチンと治療ワクチンの開発の増加
  • 課題
    • 高い臨床リスクと規制リスク
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 mRNAプラットフォーム市場適応症別

• 自己免疫疾患
• がん
  • 個別の治療
  • 単一がんに焦点を当てた
• 感染症
• 希少疾患
• 呼吸器疾患

第7章 mRNAプラットフォーム市場：ユーザビリティ別

• 予防ワクチン
• 治療薬
• 治療用ワクチン

第8章 mRNAプラットフォーム市場mRNAの種類別

• ヌクレオシド修飾されたmRNA
• 自己増幅mRNA
• 未修飾のmRNA

第9章 mRNAプラットフォーム市場：エンドユーザー別

• 病院とクリニック
• 製薬会社
• 調査組織

第10章 南北アメリカのmRNAプラットフォーム市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のmRNAプラットフォーム市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのmRNAプラットフォーム市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第14章 掲載企業一覧

第15章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. MRNA PLATFORM MARKET RESEARCH PROCESS
• FIGURE 2. MRNA PLATFORM MARKET SIZE, 2022 VS 2030
• FIGURE 3. MRNA PLATFORM MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. MRNA PLATFORM MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
• FIGURE 5. MRNA PLATFORM MARKET SIZE, BY USABILITY, 2022 VS 2030 (%)
• FIGURE 6. MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2022 VS 2030 (%)
• FIGURE 7. MRNA PLATFORM MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 8. MRNA PLATFORM MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. MRNA PLATFORM MARKET DYNAMICS
• FIGURE 10. MRNA PLATFORM MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. MRNA PLATFORM MARKET SIZE, BY USABILITY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. MRNA PLATFORM MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES MRNA PLATFORM MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. MRNA PLATFORM MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. MRNA PLATFORM MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. MRNA PLATFORM MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. MRNA PLATFORM MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 5. MRNA PLATFORM MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 7. MRNA PLATFORM MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. MRNA PLATFORM MARKET SIZE, BY PERSONALIZED TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. MRNA PLATFORM MARKET SIZE, BY SINGLE CANCER FOCUSSED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. MRNA PLATFORM MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. MRNA PLATFORM MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 14. MRNA PLATFORM MARKET SIZE, BY PROPHYLACTIC VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 18. MRNA PLATFORM MARKET SIZE, BY NUCLEOSIDE-MODIFIED MRNA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. MRNA PLATFORM MARKET SIZE, BY SELF-AMPLIFYING MRNA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. MRNA PLATFORM MARKET SIZE, BY UNMODIFIED MRNA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. MRNA PLATFORM MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. MRNA PLATFORM MARKET SIZE, BY RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. CANADA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 42. CANADA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 43. CANADA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 44. CANADA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES MRNA PLATFORM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. CHINA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 69. CHINA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 70. CHINA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 71. CHINA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 72. CHINA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. INDIA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 74. INDIA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 75. INDIA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 76. INDIA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 77. INDIA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. TAIWAN MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. EGYPT MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. FINLAND MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. FRANCE MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. GERMANY MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. ISRAEL MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 159. ITALY MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 160. ITALY MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 161. ITALY MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 162. ITALY MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 163. ITALY MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. NETHERLANDS MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. NIGERIA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 174. NORWAY MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. POLAND MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 180. POLAND MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 181. POLAND MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 182. POLAND MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 183. POLAND MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 184. QATAR MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 185. QATAR MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 186. QATAR MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 187. QATAR MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 188. QATAR MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 189. RUSSIA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 194. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 204. SPAIN MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 209. SWEDEN MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 214. SWITZERLAND MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 219. TURKEY MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 234. MRNA PLATFORM MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 235. MRNA PLATFORM MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 236. MRNA PLATFORM MARKET LICENSE & PRICING

The Global mRNA Platform Market is forecasted to grow significantly, with a projected USD 8,400.58 million in 2023 at a CAGR of 49.67% and expected to reach a staggering USD 154,820.21 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global mRNA Platform Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global mRNA Platform Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Indication, market is studied across Autoimmune Diseases, Cancer, Infectious Diseases, Rare Diseases, and Respiratory Diseases. The Cancer is further studied across Personalized Treatment and Single Cancer Focussed. The Autoimmune Diseases is projected to witness significant market share during forecast period.

Based on Usability, market is studied across Prophylactic Vaccines, Therapeutic Drugs, and Therapeutic Vaccines. The Therapeutic Vaccines is projected to witness significant market share during forecast period.

Based on mRNA Type, market is studied across Nucleoside-Modified mRNA, Self-Amplifying mRNA, and Unmodified mRNA. The Self-Amplifying mRNA is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Hospitals & Clinics, Pharmaceutical Companies, and Research Organization. The Pharmaceutical Companies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global mRNA Platform Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global mRNA Platform Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global mRNA Platform Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global mRNA Platform Market?

4. What is the competitive strategic window for opportunities in the Global mRNA Platform Market?

5. What are the technology trends and regulatory frameworks in the Global mRNA Platform Market?

6. What is the market share of the leading vendors in the Global mRNA Platform Market?

7. What modes and strategic moves are considered suitable for entering the Global mRNA Platform Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. mRNA Platform Market, by Indication, 2022 vs 2030
• 4.3. mRNA Platform Market, by Usability, 2022 vs 2030
• 4.4. mRNA Platform Market, by mRNA Type, 2022 vs 2030
• 4.5. mRNA Platform Market, by End-User, 2022 vs 2030
• 4.6. mRNA Platform Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Significant mRNA advantages over other vaccine modalities
    • 5.1.1.2. Developing therapeutic cancer treatment, exploiting mRNA platform
    • 5.1.1.3. Need to reduce vaccine development and commercialization timeline
  • 5.1.2. Restraints
    • 5.1.2.1. Complexity in optimising manufacturing and commercial pathways
  • 5.1.3. Opportunities
    • 5.1.3.1. Increased market capitalization and public funding
    • 5.1.3.2. mRNA technology optimization on development of on-demand vaccines
    • 5.1.3.3. Increased development in prophylactic vaccines and therapeutic vaccines
  • 5.1.4. Challenges
    • 5.1.4.1. High clinical and regulatory risk
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. mRNA Platform Market, by Indication

• 6.1. Introduction
• 6.2. Autoimmune Diseases
• 6.3. Cancer
  • 6.3.1. Personalized Treatment
  • 6.3.2. Single Cancer Focussed
• 6.4. Infectious Diseases
• 6.5. Rare Diseases
• 6.6. Respiratory Diseases

7. mRNA Platform Market, by Usability

• 7.1. Introduction
• 7.2. Prophylactic Vaccines
• 7.3. Therapeutic Drugs
• 7.4. Therapeutic Vaccines

8. mRNA Platform Market, by mRNA Type

• 8.1. Introduction
• 8.2. Nucleoside-Modified mRNA
• 8.3. Self-Amplifying mRNA
• 8.4. Unmodified mRNA

9. mRNA Platform Market, by End-User

• 9.1. Introduction
• 9.2. Hospitals & Clinics
• 9.3. Pharmaceutical Companies
• 9.4. Research Organization

10. Americas mRNA Platform Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific mRNA Platform Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa mRNA Platform Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing